Clinical Trial Update: A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update covers a study evaluating the safety and efficacy of PRV111, PRV211, and PRV131 in patients with oral squamous cell carcinoma, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• PRV111
• PRV131
• PRV211

Snippet

Sponsor: Privo Technologies | Conditions: Oral Squamous Cell Carcinoma | Phase 2, Phase 3 | Status: RECRUITING